EPCRI: May Annual Meeting
Registered for this event? Login now to view additional event details.
Please join us at this long-awaited opportunity to be together in-person at our annual meeting. There will be plenty of space to adhere to social distancing, including outdoors, weather permitting.
DATE: Monday, May 16, 2022
PLACE: Hope Club
6 Benevolent Street, Providence, RI
TIME: 5:00 pm – 6:00 pm Beverages & Hors d’oeuvres
6:00 pm Dinner
6:45 pm Annual Business Meeting
7:00 pm Presentation
TOPIC: Breakthroughs: Can Alzheimer’s Disease be Prevented, Slowed or Cured?
Alzheimer's disease -- often called "the long good-bye" -- can last more than a decade and has become a leading cause of death among those age 65 and older. According to 2021 data, there are currently more than 6 million Americans living with Alzheimer’s and that is expected to double to nearly 13 million by 2050. The growing size of the population living with the disease is placing a significant burden on families in addition to a strain on the health care system. Dr. Stephen Salloway will discuss not only the phases of Alzheimer’s, but recent approaches in prevention, current research, and development of therapeutics.
SPEAKER:
Stephen Salloway, MD, MS, is the Martin M. Zucker Professor of Psychiatry and Human Behavior, and Professor of Neurology at the Warren Alpert Medical School of Brown University, the Chief of Neurology and Director of the Memory and Aging Program at Butler Hospital, and the Associate Director of the Brown University Center for Alzheimer’s Disease Research. He is an internationally recognized leader in clinical trials for the prevention and treatment of Alzheimer’s Disease. He has been a lead author for key publications in top-tier journals that have helped shape the field of Alzheimer’s research.
Dr. Salloway received his MD from Stanford Medical School and completed residencies in neurology and psychiatry at Yale University.
This is a Member Only event. Registration is now closed.
